Tufts University Logo HNRCA

Search  GO >

this site tufts.edu people
 
HNRCA HNRCA HNRCA  
 
HNRCA HNRCA
Print

Stefania Lamon-Fava, M.D., Ph.D.

Stefania Lamon-Fava Scientist I
Lipid Metabolism Laboratory
Jean Mayer USDA HNRCA at Tufts University
711 Washington Street
Boston, MA 02111-1524
Phone: (617) 556-3105
Fax: (617) 556-3103
E-mail: stefania.lamon-fava@tufts.edu
Education M.D., University of Padua School of Medicine, Padua, Italy
Ph.D., Molecular Biology and Cellular Pathology, University of Modena, Italy
Research Focus Hormonal replacement, nutrition, lipoproteins, and cardiovascular disease risk; molecular aspects of the regulation of apolipoprotein A-I gene expression by sex hormones
Academic Appointments Associate Professor, Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University
Selected Professional Affiliations Member, Massachusetts Medical Society
Fellow, American Heart Association

Featured HNRCA Research Publications

Friso S, Lamon-Fava S, Jang H, Schaefer EJ, Corrocher R, Choi S-W. Estrogen replacement therapy reduces total plasma homocysteine and enhances genomic DNA methylation in postmenopausal women. British Journal of Nutrition. 2007;97:617-621.

Lamon-Fava S, Postfai B, Diffenderfer M, deLuca C, O’Connor J Jr, Welty FK, Dolnikowski GG, Barrett PHR, Schaefer EJ. Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women. Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:385-391

Matthan NR, Jalbert SM, Lamon-Fava S, Dolnikowski GG, Welty FK, Barrett HR, Schaefer EJ, Lichtenstein AH. TRL, IDL and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status. Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1691-1696.

Lamon-Fava S, Barnett JB, Woods MN, McCormack C, McNamara JR, Schaefer EJ, Longcope C, Rosner B, Gorbach SL. Differences in serum sex hormone and plasma lipid levels in Caucasian and African-American premenopausal women. Journal of Clinical Endocrinology & Metabolism. 2005;90:4516-4520.

Lamon-Fava S, Micherone D. Regulation of apolipoprotein A-I gene expression: mechanism of action of estrogen and genistein. Journal of Lipid Research. 2004;45:106-112.

Other Recent Publications

Welty FK, Lichtenstein AH, Lamon-Fava S, Schaefer EJ, Marsh JB.
Effect of body mass index on apolipoprotein A-I kinetics in middle-aged men and postmenopausal women. Metabolism. 2007;56(7):910-4.

Lamon-Fava S, Diffenderfer MR, Barrett PH, Buchsbaum A, Matthan NR, Lichtenstein AH, Dolnikowski GG, Horvath K, Asztalos BF, Zago V, Schaefer EJ. Effects of different doses of atorvastatin on human apolipoprotein B-100, B-48, and A-I metabolism. Journal of Lipid Research. 2007;48(8):1746-53.

Corcoran MP, Lamon-Fava S, Fielding RA. Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty
acids and exercise.
American Journal of Clinical Nutrition. 2007;85(3):662-77.

Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PW, Wolf PA. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.
Archives of Neurology. 2006;63(11):1545-50.

Jenner JL, Seman LJ, Millar JS, Lamon-Fava S, Welty FK, Dolnikowski GG, Marcovina SM, Lichtenstein AH, Barrett PH, deLuca C, Schaefer EJ. The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings. Metabolism. 2005;54(3):361-9.

Cendoroglo MS, Lahoz C, Martinez TL, Ordovas JM, Lamon-Fava S, Cupples LA, Wilson PW, Schaefer EJ. Association of apo A-IV 360 (Gln --> His) polymorphism with plasma lipids and lipoproteins: the Framingham Offspring Study. Atherosclerosis. 2005;179(1):169-75.

Kajinami K, Brousseau ME, Lamon-Fava S, Ordovas JM, Schaefer EJ. Gender-specific effects of estrogen receptor alpha gene haplotype on high-density lipoprotein cholesterol response to atorvastatin: interaction with apolipoprotein AI gene polymorphism. Atherosclerosis. 2005;178(2):331-8.

Batista MC, Welty FK, Diffenderfer MR, Sarnak MJ, Schaefer EJ, Lamon-Fava S, Asztalos BF, Dolnikowski GG, Brousseau ME, Marsh JB. Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome. Metabolism. 2004;53(10):1255-61.

Li Z, Lamon-Fava S, Otvos J, Lichtenstein AH, Velez-Carrasco W, McNamara JR, Ordovas JM, Schaefer EJ. Fish consumption shifts lipoprotein subfractions to a less atherogenic pattern in humans. Journal of Nutrition. 2004;134(7):1724-8.

Barnett JB, Woods MN, Lamon-Fava S, Schaefer EJ, McNamara JR, Spiegelman D, Hertzmark E, Goldin B, Longcope C, Gorbach SL. Plasma lipid and lipoprotein levels during the follicular and luteal phases of the menstrual cycle. Journal of Clinical Endocrinology & Metabolism. 2004;89(2):776-82.

Li Z, Otvos JD, Lamon-Fava S, Carrasco WV, Lichtenstein AH, McNamara JR, Ordovas JM, Schaefer EJ. Men and women differ in lipoprotein response to dietary saturated fat and cholesterol restriction. Journal of Nutrition. 2003;133(11):3428-33.

To see more of Dr. Stefania Lamon-Fava's publications, please visit PubMed and search for "Lamon-Fava S."